NCT03345953View on ClinicalTrials.gov

Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome

PHASE2TerminatedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

April 29, 2020

Study Completion Date

April 29, 2020

Conditions
Restless Legs Syndrome
Interventions
DRUG

BP 1.4979

Double blind versus placebo

DRUG

Placebo

Double blind versus placebo

Trial Locations (1)

33076

Clinical Neurophysiology Department - Hôpital Pellegrin, Bordeaux

Sponsors

Lead Sponsor

Bioprojet
All Listed Sponsors
lead

Bioprojet

OTHER